FDA Approved: NULOJIX — Supplemental Application (E.R. Squibb & Sons, L.L.C.)

View source ↗

Summary

FDA approves a supplemental application for NULOJIX (belatacept) from E.R. Squibb & Sons, L.L.C., under BLA125288.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplant Rejection

Drugs mentioned

• Nulojix (belatacept)

Snippet

SUPPL AP for NULOJIX (BELATACEPT)